 The drug being tested in this study is called leuprorelin. It is administered as a 1 month subcutaneous depot. Leuprorelin is being tested to treat children who have CPP. This study will look at the development of internal and external genital organs and appearance of secondary sexual characteristics in pre-pubertal children who take leuprorelin. 